We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
(+14%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$157M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$117M |
| 3 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$105M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$94M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$63.3M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$32.3M |
| 3 |
Schwab US REIT ETF
SCHH
|
+$21.3M |
| 4 |
Vanguard Energy ETF
VDE
|
+$18.8M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.74% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 2.19% |
| 4 | Energy | 2.03% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
326
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.71M | 0.01% |
+33,175
| New | +$3.62M |
|
327
Chipotle Mexican Grill
CMG
$40.8B
| $3.7M | 0.01% |
260,150
-195,550
| -43% | -$2.27M |
|
328
Marriott International
MAR
$98.7B
| $3.67M | 0.01% |
29,298
-921
| -3% | -$108K |
|
329
Veeva Systems
VEEV
$30.3B
| $3.63M | 0.01% |
28,654
+10,419
| +57% | +$1.18M |
|
330
Archer Daniels Midland
ADM
$41.4B
| $3.63M | 0.01% |
84,191
+557
| +0.7% | +$23.8K |
|
|
BNY
331
Bank of New York Mellon
BNY
$108B
| $3.62M | 0.01% |
71,866
-2,317
| -3% | -$119K |
|
332
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $3.56M | 0.01% |
69,315
-570
| -0.8% | -$30.4K |
|
333
PNC Financial Services
PNC
$100B
| $3.54M | 0.01% |
28,867
+419
| +1% | +$51.9K |
|
334
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
| $3.5M | 0.01% |
40,356
-2,815
| -7% | -$237K |
|
335
United Bankshares
UBSI
$6.55B
| $3.5M | 0.01% |
96,659
+28
| +0% | +$1.01K |
|
336
Vanguard Mid-Cap Growth ETF
VOT
$19B
| $3.5M | 0.01% |
24,521
+215
| +0.9% | +$28.9K |
|
337
L3Harris
LHX
$55.9B
| $3.5M | 0.01% |
21,882
-36
| -0.2% | -$5.54K |
|
|
CLVS
338
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.46M | 0.01% |
139,550
+1,513
| +1% | +$37.9K |
|
339
Linde
LIN
$237B
| $3.45M | 0.01% |
19,614
-3,379
| -15% | -$561K |
|
340
HCI Group
HCI
$2.28B
| $3.45M | 0.01% |
80,642
| – | – |
|
341
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
| $3.42M | 0.01% |
62,388
+340
| +0.5% | +$17.9K |
|
|
AKS
342
DELISTED
AK Steel Holding Corp
AKS
| $3.42M | 0.01% |
1,242,487
-342,500
| -22% | -$971K |
|
|
ATRI
343
DELISTED
Atrion Corp
ATRI
| $3.41M | 0.01% |
3,879
-803
| -17% | -$633K |
|
344
Eaton
ETN
$157B
| $3.4M | 0.01% |
42,272
+2,281
| +6% | +$174K |
|
345
WEC Energy
WEC
$37.7B
| $3.4M | 0.01% |
42,940
-1,864
| -4% | -$138K |
|
346
Public Service Enterprise Group
PEG
$39.8B
| $3.35M | 0.01% |
56,467
-4,941
| -8% | -$276K |
|
347
Chubb
CB
$140B
| $3.35M | 0.01% |
23,889
+601
| +3% | +$79.9K |
|
|
APC
348
DELISTED
Anadarko Petroleum
APC
| $3.35M | 0.01% |
73,576
-2,141
| -3% | -$97.1K |
|
349
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
| $3.25M | 0.01% |
57,186
+8,288
| +17% | +$449K |
|
350
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $3.24M | 0.01% |
35,825
+1,038
| +3% | +$88.3K |
|
Similar funds
Creative Planning's Q1 2019 Portfolio in Review
As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.
- Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
- Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
- Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
- Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
- Creative Planning opened 217 new positions and closed 175 in Q1 2019.
- Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.
Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.